Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Post by whisky11on Jun 20, 2022 4:10pm
258 Views
Post# 34769612

From Yahoo board

From Yahoo boardShared From Reddit for what it is worth.. Correspondence update with Faraaz Jamal
T:I understand you are putting CELLF through clinical studies to prove the efficacy of the product, is there an expected timeframe for Mikra to publish those results? The first few days have been going well as I certainly feel more energized, but at the same time I am still not sure if I have tricked myself into a placebo effect, haha. Are you able to disclose in what ways you evaluated the effects of the product in your smaller test groups?

F:I'm thrilled to hear you've had some positive initial effects. They'll keep coming :). I hear you on the placebo effect, and if this were a pill/powder without our transferrin technology, I'd be inclined to agree with you. However, what we've created is something unique and efficacious.

We'll be publishing our cellular and molecular studies towards the end of this year. We're kicking off another open-label study that will transition into a double-blind in the coming months. I can't disclose our results on our beta group (yet), but I expect to have that out within two months. We were hyper targeted around individuals with Long COVID and CFS/ME.
<< Previous
Bullboard Posts
Next >>